>>only one response out of 27 pts given monotherapy But 1/1 with MRD AML, which the company said at Cowen was the indication they currently liked best. Some more details here - this patient relapsed after a stem-cell transplant: http://www.siliconinvestor.com/readmsg.aspx?msgid=31056707